An exploratory study of the efficacy and safety of yokukansan for neuropsychiatric symptoms in patients with Parkinson’s disease

Improvement in delusions and hallucinations in patients with dementia with Lewy bodies upon administration of yokukansan, a traditional Japanese medicine

(2012) Koh IWASAKI et al.   Psychogeriatrics

Isoliquiritigenin is a Novel NMDA Receptor Antagonist in Kampo Medicine Yokukansan

(2011) Zenji Kawakami et al.   CELLULAR AND MOLECULAR NEUROBIOLOGY

OPEN LABEL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF YOKUKANSAN, A TRADITIONAL ASIAN MEDICINE, IN DEMENTIA WITH LEWY BODIES

(2011) Koh Iwasaki et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease

(2011) Klaus Seppi et al.   MOVEMENT DISORDERS

Serotonin 2A Receptors and Visual Hallucinations in Parkinson Disease

(2010) Benedicte Ballanger et al.   ARCHIVES OF NEUROLOGY

Yokukansan, a kampo medicine, protects against glutamate cytotoxicity due to oxidative stress in PC12 cells

(2010) Zenji Kawakami et al.   JOURNAL OF ETHNOPHARMACOLOGY

Glycyrrhizin and its metabolite 18β-glycyrrhetinic acid in glycyrrhiza, a constituent herb of yokukansan, ameliorate thiamine deficiency-induced dysfunction of glutamate transport in cultured rat cortical astrocytes

(2009) Zenji Kawakami et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Partial agonistic effect of yokukansan on human recombinant serotonin 1A receptors expressed in the membranes of Chinese hamster ovary cells

(2009) Kiyoshi Terawaki et al.   JOURNAL OF ETHNOPHARMACOLOGY

Anxiolytic effect of a herbal medicine, yokukansan, in aged rats: Involvement of serotonergic and dopaminergic transmissions in the prefrontal cortex

(2009) Kazushige Mizoguchi et al.   JOURNAL OF ETHNOPHARMACOLOGY

Successful treatment with Yokukansan for behavioral and psychological symptoms of Parkinsonian dementia

(2009) Tadaaki Kawanabe et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Attenuation of abnormal glutamate release in zinc deficiency by zinc and Yokukansan

(2008) Atsushi Takeda et al.   NEUROCHEMISTRY INTERNATIONAL

Repeated administration of Yokukansan inhibits DOI-induced head-twitch response and decreases expression of 5-hydroxytryptamine (5-HT)2A receptors in the prefrontal cortex

(2008) Nobuaki Egashira et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY